Novel motif:22
From FANTOM5_SSTAR
name: | motif22_GGMCTG |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0010624 | regulation of Schwann cell proliferation | 1.168538e-15 |
GO:0042506 | tyrosine phosphorylation of Stat5 protein | 1.640923e-12 |
GO:0010625 | positive regulation of Schwann cell proliferation | 1.848607e-11 |
GO:0010288 | response to lead ion | 3.914670e-11 |
GO:0008078 | mesodermal cell migration | 5.937741e-11 |
GO:0042503 | tyrosine phosphorylation of Stat3 protein | 8.227879e-11 |
GO:0031440 | regulation of mRNA 3'-end processing | 8.826510e-11 |
GO:0010506 | regulation of autophagy | 2.336041e-10 |
GO:0061014 | positive regulation of mRNA catabolic process | 2.792945e-10 |
GO:0015879 | carnitine transport | 3.152432e-10 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 4.578571e-10 |
GO:0007296 | vitellogenesis | 3.319176e-9 |
GO:0060337 | type I interferon-mediated signaling pathway | 3.371575e-9 |
GO:0035814 | negative regulation of renal sodium excretion | 4.640483e-9 |
GO:0032863 | activation of Rac GTPase activity | 5.403364e-9 |
GO:0000413 | protein peptidyl-prolyl isomerization | 6.192350e-9 |
GO:0034340 | response to type I interferon | 7.039940e-9 |
GO:0043503 | skeletal muscle fiber adaptation | 7.652424e-9 |
GO:0071732 | cellular response to nitric oxide | 7.827064e-9 |
GO:0030037 | actin filament reorganization involved in cell cycle | 8.283362e-9 |
GO:0035966 | response to topologically incorrect protein | 8.869105e-9 |
GO:0006544 | glycine metabolic process | 1.562699e-8 |
GO:0035313 | wound healing, spreading of epidermal cells | 1.663216e-8 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 3.060716e-8 |
GO:0045112 | integrin biosynthetic process | 3.466641e-8 |
GO:0061383 | trabecula morphogenesis | 4.328632e-8 |
GO:0006457 | protein folding | 4.737104e-8 |
GO:0015936 | coenzyme A metabolic process | 7.084570e-8 |
GO:0090241 | negative regulation of histone H4 acetylation | 8.242388e-8 |
GO:0060343 | trabecula formation | 1.000078e-7 |
GO:0034505 | tooth mineralization | 1.021895e-7 |
GO:0022009 | central nervous system vasculogenesis | 1.455284e-7 |
GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus | 1.586690e-7 |
GO:0043206 | fibril organization | 1.627445e-7 |
GO:0048242 | epinephrine secretion | 1.702808e-7 |
GO:0015939 | pantothenate metabolic process | 1.789727e-7 |
GO:0043585 | nose morphogenesis | 1.792528e-7 |
GO:0006853 | carnitine shuttle | 2.032253e-7 |
GO:0002528 | regulation of vascular permeability involved in acute inflammatory response | 2.118505e-7 |
GO:0035854 | eosinophil fate commitment | 2.159974e-7 |
GO:0030222 | eosinophil differentiation | 2.159974e-7 |
GO:0042891 | antibiotic transport | 2.221395e-7 |
GO:0031330 | negative regulation of cellular catabolic process | 2.413613e-7 |
GO:0043088 | regulation of Cdc42 GTPase activity | 2.435893e-7 |
GO:0044319 | wound healing, spreading of cells | 2.613213e-7 |
GO:0070483 | detection of hypoxia | 2.715774e-7 |
GO:0042508 | tyrosine phosphorylation of Stat1 protein | 2.896212e-7 |
GO:0072321 | chaperone-mediated protein transport | 3.480324e-7 |
GO:0050779 | RNA destabilization | 4.340953e-7 |
GO:0006986 | response to unfolded protein | 4.588974e-7 |
GO:0031329 | regulation of cellular catabolic process | 4.991576e-7 |
GO:0031282 | regulation of guanylate cyclase activity | 6.393152e-7 |
GO:0055026 | negative regulation of cardiac muscle tissue development | 7.087665e-7 |
GO:0043462 | regulation of ATPase activity | 7.381566e-7 |
GO:0036006 | cellular response to macrophage colony-stimulating factor stimulus | 7.639251e-7 |
GO:0018208 | peptidyl-proline modification | 7.978315e-7 |
GO:0050685 | positive regulation of mRNA processing | 8.220144e-7 |
GO:0007006 | mitochondrial membrane organization | 9.212261e-7 |
GO:0071731 | response to nitric oxide | 9.657666e-7 |
GO:0090084 | negative regulation of inclusion body assembly | 1.305575e-6 |
GO:0010626 | negative regulation of Schwann cell proliferation | 1.336166e-6 |
GO:0032956 | regulation of actin cytoskeleton organization | 1.351129e-6 |
GO:0019221 | cytokine-mediated signaling pathway | 1.513655e-6 |
GO:0070715 | sodium-dependent organic cation transport | 1.530507e-6 |
GO:0060731 | positive regulation of intestinal epithelial structure maintenance | 1.530507e-6 |
GO:0052106 | quorum sensing involved in interaction with host | 1.530507e-6 |
GO:0051029 | rRNA transport | 1.602987e-6 |
GO:0007028 | cytoplasm organization | 1.646372e-6 |
GO:0010896 | regulation of triglyceride catabolic process | 1.667964e-6 |
GO:0060346 | bone trabecula formation | 1.675805e-6 |
GO:0031064 | negative regulation of histone deacetylation | 1.680799e-6 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 1.740082e-6 |
GO:0032862 | activation of Rho GTPase activity | 1.885477e-6 |
GO:0032970 | regulation of actin filament-based process | 1.939425e-6 |
GO:0007509 | mesoderm migration involved in gastrulation | 2.024079e-6 |
GO:0045039 | protein import into mitochondrial inner membrane | 2.071387e-6 |
GO:0032312 | regulation of ARF GTPase activity | 2.096380e-6 |
GO:0060251 | regulation of glial cell proliferation | 2.372717e-6 |
GO:0060730 | regulation of intestinal epithelial structure maintenance | 2.566361e-6 |
GO:0060491 | regulation of cell projection assembly | 2.639300e-6 |
GO:0032926 | negative regulation of activin receptor signaling pathway | 2.845236e-6 |
GO:0061028 | establishment of endothelial barrier | 3.168811e-6 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 3.218148e-6 |
GO:0043314 | negative regulation of neutrophil degranulation | 3.272169e-6 |
GO:0014044 | Schwann cell development | 3.291736e-6 |
GO:0071276 | cellular response to cadmium ion | 3.456199e-6 |
GO:0048708 | astrocyte differentiation | 3.815132e-6 |
GO:0007021 | tubulin complex assembly | 3.992095e-6 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 4.234144e-6 |
GO:0006545 | glycine biosynthetic process | 4.413051e-6 |
GO:0006984 | ER-nucleus signaling pathway | 5.205506e-6 |
GO:0002886 | regulation of myeloid leukocyte mediated immunity | 5.733114e-6 |
GO:0008624 | induction of apoptosis by extracellular signals | 6.283515e-6 |
GO:0002098 | tRNA wobble uridine modification | 6.486772e-6 |
GO:0072488 | ammonium transmembrane transport | 6.486772e-6 |
GO:0034227 | tRNA thio-modification | 6.486772e-6 |
GO:0044342 | type B pancreatic cell proliferation | 6.518774e-6 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 6.518774e-6 |
GO:0001892 | embryonic placenta development | 6.981705e-6 |
GO:0070345 | negative regulation of fat cell proliferation | 7.095139e-6 |
GO:0043249 | erythrocyte maturation | 7.193554e-6 |
GO:0033209 | tumor necrosis factor-mediated signaling pathway | 7.318818e-6 |
GO:0007007 | inner mitochondrial membrane organization | 7.445866e-6 |
GO:0032231 | regulation of actin filament bundle assembly | 7.626617e-6 |
GO:0046320 | regulation of fatty acid oxidation | 8.399849e-6 |
GO:0071260 | cellular response to mechanical stimulus | 9.878524e-6 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 9.907314e-6 |
GO:0046655 | folic acid metabolic process | 1.030253e-5 |
GO:0090130 | tissue migration | 1.035144e-5 |
GO:0051016 | barbed-end actin filament capping | 1.098475e-5 |
GO:0060020 | Bergmann glial cell differentiation | 1.220371e-5 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 1.228074e-5 |
GO:0032374 | regulation of cholesterol transport | 1.313781e-5 |
GO:0043300 | regulation of leukocyte degranulation | 1.323698e-5 |
GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate | 1.368694e-5 |
GO:0046724 | oxalic acid secretion | 1.368694e-5 |
GO:0031284 | positive regulation of guanylate cyclase activity | 1.392541e-5 |
GO:0015937 | coenzyme A biosynthetic process | 1.435073e-5 |
GO:0032720 | negative regulation of tumor necrosis factor production | 1.476549e-5 |
GO:0070498 | interleukin-1-mediated signaling pathway | 1.564316e-5 |
GO:0045415 | negative regulation of interleukin-8 biosynthetic process | 1.577719e-5 |
GO:0045085 | negative regulation of interleukin-2 biosynthetic process | 1.578959e-5 |
GO:0022011 | myelination in peripheral nervous system | 1.631483e-5 |
GO:0043313 | regulation of neutrophil degranulation | 1.916785e-5 |
GO:0045351 | type I interferon biosynthetic process | 1.945979e-5 |
GO:0046626 | regulation of insulin receptor signaling pathway | 2.014761e-5 |
GO:0033505 | floor plate morphogenesis | 2.051758e-5 |
GO:0014002 | astrocyte development | 2.106509e-5 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 2.160594e-5 |
GO:0032232 | negative regulation of actin filament bundle assembly | 2.287693e-5 |
GO:0046325 | negative regulation of glucose import | 2.392421e-5 |
GO:0006914 | autophagy | 2.531855e-5 |
GO:0022617 | extracellular matrix disassembly | 2.623461e-5 |
GO:0090083 | regulation of inclusion body assembly | 3.289205e-5 |
GO:0014037 | Schwann cell differentiation | 3.322127e-5 |
GO:0035928 | rRNA import into mitochondrion | 3.392223e-5 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 3.443420e-5 |
GO:0061013 | regulation of mRNA catabolic process | 3.670788e-5 |
GO:0019264 | glycine biosynthetic process from serine | 3.727769e-5 |
GO:0007141 | male meiosis I | 3.775672e-5 |
GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process | 3.789506e-5 |
GO:0002017 | regulation of blood volume by renal aldosterone | 3.794845e-5 |
GO:0048261 | negative regulation of receptor-mediated endocytosis | 4.201725e-5 |
GO:0090239 | regulation of histone H4 acetylation | 4.326096e-5 |
GO:0032964 | collagen biosynthetic process | 4.486250e-5 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 4.691658e-5 |
GO:0010874 | regulation of cholesterol efflux | 4.812787e-5 |
GO:0060620 | regulation of cholesterol import | 4.839586e-5 |
GO:0042117 | monocyte activation | 4.862268e-5 |
GO:0051580 | regulation of neurotransmitter uptake | 4.993997e-5 |
GO:0009650 | UV protection | 5.284441e-5 |
GO:0060311 | negative regulation of elastin catabolic process | 5.377340e-5 |
GO:0060313 | negative regulation of blood vessel remodeling | 5.377340e-5 |
GO:0010711 | negative regulation of collagen catabolic process | 5.377340e-5 |
GO:0010703 | negative regulation of histolysis | 5.377340e-5 |
GO:0051492 | regulation of stress fiber assembly | 5.393424e-5 |
GO:0032474 | otolith morphogenesis | 5.463539e-5 |
GO:0048382 | mesendoderm development | 5.581481e-5 |
GO:0048144 | fibroblast proliferation | 6.083634e-5 |
GO:0033159 | negative regulation of protein import into nucleus, translocation | 6.083634e-5 |
GO:0001880 | Mullerian duct regression | 6.083634e-5 |
GO:0030433 | ER-associated protein catabolic process | 6.114759e-5 |
GO:0032855 | positive regulation of Rac GTPase activity | 6.651104e-5 |
GO:0033239 | negative regulation of cellular amine metabolic process | 6.760143e-5 |
GO:0032929 | negative regulation of superoxide anion generation | 6.760143e-5 |
GO:0018879 | biphenyl metabolic process | 6.905407e-5 |
GO:0045806 | negative regulation of endocytosis | 7.093415e-5 |
GO:0009070 | serine family amino acid biosynthetic process | 7.205976e-5 |
GO:0045940 | positive regulation of steroid metabolic process | 7.221106e-5 |
GO:0048241 | epinephrine transport | 7.420523e-5 |
GO:0016236 | macroautophagy | 7.471402e-5 |
GO:0006956 | complement activation | 7.604627e-5 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 8.299403e-5 |
GO:0010897 | negative regulation of triglyceride catabolic process | 8.299403e-5 |
GO:0006526 | arginine biosynthetic process | 8.299403e-5 |
GO:0033197 | response to vitamin E | 8.726121e-5 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 8.839650e-5 |
GO:0072061 | inner medullary collecting duct development | 9.624193e-5 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 9.624193e-5 |
GO:0072060 | outer medullary collecting duct development | 9.624193e-5 |
GO:0007635 | chemosensory behavior | 1.014044e-4 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 1.027498e-4 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 1.050613e-4 |
GO:0044062 | regulation of excretion | 1.109771e-4 |
GO:0007260 | tyrosine phosphorylation of STAT protein | 1.115814e-4 |
GO:0009894 | regulation of catabolic process | 1.219951e-4 |
GO:0015695 | organic cation transport | 1.230866e-4 |
GO:0046069 | cGMP catabolic process | 1.327546e-4 |
GO:0046687 | response to chromate | 1.336239e-4 |
GO:0033986 | response to methanol | 1.336239e-4 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 1.412643e-4 |
GO:0097152 | mesenchymal cell apoptosis | 1.412643e-4 |
GO:0002438 | acute inflammatory response to antigenic stimulus | 1.412643e-4 |
GO:0060982 | coronary artery morphogenesis | 1.412643e-4 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 1.418272e-4 |
GO:0000115 | regulation of transcription involved in S phase of mitotic cell cycle | 1.433527e-4 |
GO:0046474 | glycerophospholipid biosynthetic process | 1.437476e-4 |
GO:0009895 | negative regulation of catabolic process | 1.448440e-4 |
GO:0044240 | multicellular organismal lipid catabolic process | 1.470500e-4 |
GO:0048320 | axial mesoderm formation | 1.514788e-4 |
GO:0042074 | cell migration involved in gastrulation | 1.535283e-4 |
GO:0060872 | semicircular canal development | 1.599074e-4 |
GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair | 1.620442e-4 |
GO:0006702 | androgen biosynthetic process | 1.624467e-4 |
GO:0090207 | regulation of triglyceride metabolic process | 1.649695e-4 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 1.743757e-4 |
GO:0006085 | acetyl-CoA biosynthetic process | 1.743757e-4 |
GO:0033601 | positive regulation of mammary gland epithelial cell proliferation | 1.767303e-4 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 1.767303e-4 |
GO:0046039 | GTP metabolic process | 1.778001e-4 |
GO:0002019 | regulation of renal output by angiotensin | 1.825493e-4 |
GO:0006767 | water-soluble vitamin metabolic process | 1.858253e-4 |
GO:0051693 | actin filament capping | 1.862963e-4 |
GO:0021526 | medial motor column neuron differentiation | 1.915755e-4 |
GO:0033133 | positive regulation of glucokinase activity | 1.915788e-4 |
GO:0060621 | negative regulation of cholesterol import | 1.915788e-4 |
GO:0016241 | regulation of macroautophagy | 1.917962e-4 |
GO:0045453 | bone resorption | 1.963410e-4 |
GO:0008033 | tRNA processing | 1.989253e-4 |
GO:0003084 | positive regulation of systemic arterial blood pressure | 2.080709e-4 |
GO:0097107 | postsynaptic density assembly | 2.162148e-4 |
GO:0050668 | positive regulation of homocysteine metabolic process | 2.162148e-4 |
GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 2.162148e-4 |
GO:0045963 | negative regulation of dopamine metabolic process | 2.162148e-4 |
GO:0015878 | biotin transport | 2.162148e-4 |
GO:0015887 | pantothenate transmembrane transport | 2.162148e-4 |
GO:0051956 | negative regulation of amino acid transport | 2.179338e-4 |
GO:0010591 | regulation of lamellipodium assembly | 2.185504e-4 |
GO:0070634 | transepithelial ammonium transport | 2.228202e-4 |
GO:0006184 | GTP catabolic process | 2.276994e-4 |
GO:0031017 | exocrine pancreas development | 2.304856e-4 |
GO:0010507 | negative regulation of autophagy | 2.319569e-4 |
GO:0035967 | cellular response to topologically incorrect protein | 2.323100e-4 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 2.372643e-4 |
GO:0010713 | negative regulation of collagen metabolic process | 2.401319e-4 |
GO:0060707 | trophoblast giant cell differentiation | 2.441554e-4 |
GO:0046686 | response to cadmium ion | 2.442416e-4 |
GO:0052697 | xenobiotic glucuronidation | 2.473298e-4 |
GO:0060286 | flagellar cell motility | 2.473298e-4 |
GO:0070980 | biphenyl catabolic process | 2.473298e-4 |
GO:0052696 | flavonoid glucuronidation | 2.473298e-4 |
GO:0002077 | acrosome matrix dispersal | 2.473298e-4 |
GO:0006789 | bilirubin conjugation | 2.473298e-4 |
GO:0051552 | flavone metabolic process | 2.473298e-4 |
GO:0021528 | commissural neuron differentiation in spinal cord | 2.473298e-4 |
GO:0051315 | attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation | 2.473298e-4 |
GO:0051497 | negative regulation of stress fiber assembly | 2.493756e-4 |
GO:0032526 | response to retinoic acid | 2.521025e-4 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 2.558632e-4 |
GO:0003136 | negative regulation of heart induction by canonical Wnt receptor signaling pathway | 2.646438e-4 |
GO:0042512 | negative regulation of tyrosine phosphorylation of Stat1 protein | 2.646438e-4 |
GO:0050666 | regulation of homocysteine metabolic process | 2.704732e-4 |
GO:0070286 | axonemal dynein complex assembly | 2.763859e-4 |
GO:0051489 | regulation of filopodium assembly | 2.794780e-4 |
GO:0032796 | uropod organization | 2.795782e-4 |
GO:0060253 | negative regulation of glial cell proliferation | 2.830262e-4 |
GO:0003105 | negative regulation of glomerular filtration | 2.860548e-4 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 2.867462e-4 |
GO:2000251 | positive regulation of actin cytoskeleton reorganization | 3.047440e-4 |
GO:0060167 | regulation of adenosine receptor signaling pathway | 3.047440e-4 |
GO:0031125 | rRNA 3'-end processing | 3.047440e-4 |
GO:0060456 | positive regulation of digestive system process | 3.050932e-4 |
GO:0045814 | negative regulation of gene expression, epigenetic | 3.155565e-4 |
GO:0045217 | cell-cell junction maintenance | 3.158542e-4 |
GO:0002432 | granuloma formation | 3.248196e-4 |
GO:0046902 | regulation of mitochondrial membrane permeability | 3.321836e-4 |
GO:0043574 | peroxisomal transport | 3.482788e-4 |
GO:0042274 | ribosomal small subunit biogenesis | 3.514584e-4 |
GO:0009069 | serine family amino acid metabolic process | 3.555211e-4 |
GO:0071356 | cellular response to tumor necrosis factor | 3.577041e-4 |
GO:0051567 | histone H3-K9 methylation | 3.605766e-4 |
GO:0006659 | phosphatidylserine biosynthetic process | 3.609730e-4 |
GO:0003009 | skeletal muscle contraction | 3.614542e-4 |
GO:0071318 | cellular response to ATP | 3.665935e-4 |
GO:0006839 | mitochondrial transport | 3.696960e-4 |
GO:0045746 | negative regulation of Notch signaling pathway | 3.743120e-4 |
GO:0048627 | myoblast development | 3.797723e-4 |
GO:0045835 | negative regulation of meiosis | 3.881417e-4 |
GO:0007195 | inhibition of adenylate cyclase activity by dopamine receptor signaling pathway | 3.912265e-4 |
GO:0045084 | positive regulation of interleukin-12 biosynthetic process | 4.087539e-4 |
GO:0007140 | male meiosis | 4.306092e-4 |
GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process | 4.310755e-4 |
GO:0061302 | smooth muscle cell-matrix adhesion | 4.310755e-4 |
GO:0010875 | positive regulation of cholesterol efflux | 4.547436e-4 |
GO:0006657 | CDP-choline pathway | 4.782904e-4 |
GO:0005979 | regulation of glycogen biosynthetic process | 4.911030e-4 |
GO:0032376 | positive regulation of cholesterol transport | 5.045695e-4 |
GO:0006625 | protein targeting to peroxisome | 5.127809e-4 |
GO:0060319 | primitive erythrocyte differentiation | 5.130403e-4 |
GO:0002575 | basophil chemotaxis | 5.130403e-4 |
GO:0060706 | cell differentiation involved in embryonic placenta development | 5.147682e-4 |
GO:0070625 | zymogen granule exocytosis | 5.262277e-4 |
GO:0014895 | smooth muscle hypertrophy | 5.262277e-4 |
GO:0003106 | negative regulation of glomerular filtration by angiotensin | 5.262277e-4 |
GO:0048484 | enteric nervous system development | 5.329684e-4 |
GO:0072053 | renal inner medulla development | 5.342737e-4 |
GO:0072054 | renal outer medulla development | 5.342737e-4 |
GO:0071072 | negative regulation of phospholipid biosynthetic process | 5.342737e-4 |
GO:0051764 | actin crosslink formation | 5.446611e-4 |
GO:0060179 | male mating behavior | 5.459426e-4 |
GO:0032375 | negative regulation of cholesterol transport | 5.705207e-4 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 5.720123e-4 |
GO:0032793 | positive regulation of CREB transcription factor activity | 5.807390e-4 |
GO:0072376 | protein activation cascade | 5.881335e-4 |
GO:0010891 | negative regulation of sequestering of triglyceride | 5.890036e-4 |
GO:0035813 | regulation of renal sodium excretion | 5.942105e-4 |
GO:0015804 | neutral amino acid transport | 5.977165e-4 |
GO:0060014 | granulosa cell differentiation | 6.094904e-4 |
GO:0070914 | UV-damage excision repair | 6.539055e-4 |
GO:0060160 | negative regulation of dopamine receptor signaling pathway | 6.539055e-4 |
GO:0015840 | urea transport | 6.687215e-4 |
GO:0032509 | endosome transport via multivesicular body sorting pathway | 6.820227e-4 |
GO:0050975 | sensory perception of touch | 6.892288e-4 |
GO:0021508 | floor plate formation | 7.405179e-4 |
GO:0015862 | uridine transport | 7.405179e-4 |
GO:0070417 | cellular response to cold | 7.411331e-4 |
GO:0031643 | positive regulation of myelination | 7.545856e-4 |
GO:0045541 | negative regulation of cholesterol biosynthetic process | 7.683870e-4 |
GO:0030421 | defecation | 7.683870e-4 |
GO:0019370 | leukotriene biosynthetic process | 7.705394e-4 |
GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 7.706094e-4 |
GO:0045017 | glycerolipid biosynthetic process | 7.790137e-4 |
GO:0007217 | tachykinin receptor signaling pathway | 8.018003e-4 |
GO:0060334 | regulation of interferon-gamma-mediated signaling pathway | 8.193215e-4 |
GO:0006506 | GPI anchor biosynthetic process | 8.382653e-4 |
GO:0090209 | negative regulation of triglyceride metabolic process | 8.408792e-4 |
GO:0042407 | cristae formation | 8.555683e-4 |
GO:0010637 | negative regulation of mitochondrial fusion | 8.555683e-4 |
GO:0071279 | cellular response to cobalt ion | 8.555683e-4 |
GO:0010046 | response to mycotoxin | 8.555683e-4 |
GO:0000053 | argininosuccinate metabolic process | 8.555683e-4 |
GO:0071071 | regulation of phospholipid biosynthetic process | 8.626473e-4 |
GO:0070194 | synaptonemal complex disassembly | 8.777997e-4 |
GO:0031662 | positive regulation of cyclin-dependent protein kinase activity involved in G2/M | 8.777997e-4 |
GO:0006703 | estrogen biosynthetic process | 8.835354e-4 |
GO:0046931 | pore complex assembly | 8.902211e-4 |
GO:0043301 | negative regulation of leukocyte degranulation | 9.276569e-4 |
GO:0070873 | regulation of glycogen metabolic process | 9.374030e-4 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 9.480406e-4 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 9.530312e-4 |
GO:0010724 | regulation of definitive erythrocyte differentiation | 9.595876e-4 |
GO:0071733 | transcriptional activation by promoter-enhancer looping | 9.595876e-4 |
GO:0001560 | regulation of cell growth by extracellular stimulus | 9.606484e-4 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 9.772242e-4 |
GO:0071345 | cellular response to cytokine stimulus | 9.920141e-4 |
GO:0044154 | histone H3-K14 acetylation | 9.938445e-4 |
GO:0033189 | response to vitamin A | 1.032956e-3 |
GO:0051588 | regulation of neurotransmitter transport | 1.046015e-3 |
GO:0071392 | cellular response to estradiol stimulus | 1.079235e-3 |
GO:0046456 | icosanoid biosynthetic process | 1.111925e-3 |
GO:0050432 | catecholamine secretion | 1.113664e-3 |
GO:0032298 | positive regulation of DNA-dependent DNA replication initiation | 1.119614e-3 |
GO:0002636 | positive regulation of germinal center formation | 1.152938e-3 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 1.173750e-3 |
GO:0060708 | spongiotrophoblast differentiation | 1.189560e-3 |
GO:0032606 | type I interferon production | 1.190058e-3 |
GO:0009443 | pyridoxal 5'-phosphate salvage | 1.209311e-3 |
GO:0042424 | catecholamine catabolic process | 1.212388e-3 |
GO:0030100 | regulation of endocytosis | 1.220539e-3 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 1.220987e-3 |
GO:0006768 | biotin metabolic process | 1.220987e-3 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 1.232996e-3 |
GO:0002037 | negative regulation of L-glutamate transport | 1.232996e-3 |
GO:0045994 | positive regulation of translational initiation by iron | 1.232996e-3 |
GO:0006691 | leukotriene metabolic process | 1.235581e-3 |
GO:0015858 | nucleoside transport | 1.256772e-3 |
GO:0032536 | regulation of cell projection size | 1.256866e-3 |
GO:0003229 | ventricular cardiac muscle tissue development | 1.263952e-3 |
GO:0044027 | hypermethylation of CpG island | 1.268030e-3 |
GO:0010898 | positive regulation of triglyceride catabolic process | 1.314366e-3 |
GO:0070947 | neutrophil mediated killing of fungus | 1.323214e-3 |
GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation | 1.323214e-3 |
GO:0006423 | cysteinyl-tRNA aminoacylation | 1.323214e-3 |
GO:0006706 | steroid catabolic process | 1.340196e-3 |
GO:0010906 | regulation of glucose metabolic process | 1.372586e-3 |
GO:0032012 | regulation of ARF protein signal transduction | 1.382089e-3 |
GO:0051788 | response to misfolded protein | 1.384933e-3 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 1.399491e-3 |
GO:0019217 | regulation of fatty acid metabolic process | 1.410665e-3 |
GO:0015697 | quaternary ammonium group transport | 1.422147e-3 |
GO:0030032 | lamellipodium assembly | 1.468339e-3 |
GO:0045820 | negative regulation of glycolysis | 1.472025e-3 |
GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway | 1.474031e-3 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 1.485195e-3 |
GO:0060564 | negative regulation of mitotic anaphase-promoting complex activity | 1.503317e-3 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.504363e-3 |
GO:0045078 | positive regulation of interferon-gamma biosynthetic process | 1.518496e-3 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 1.528005e-3 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 1.545099e-3 |
GO:0046777 | protein autophosphorylation | 1.545105e-3 |
GO:0046627 | negative regulation of insulin receptor signaling pathway | 1.579956e-3 |
GO:0050764 | regulation of phagocytosis | 1.594950e-3 |
GO:0046128 | purine ribonucleoside metabolic process | 1.615369e-3 |
GO:0001885 | endothelial cell development | 1.616107e-3 |
GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter | 1.617385e-3 |
GO:0060683 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling | 1.656522e-3 |
GO:0003329 | pancreatic PP cell fate commitment | 1.656522e-3 |
GO:0003326 | pancreatic A cell fate commitment | 1.656522e-3 |
GO:0002554 | serotonin secretion by platelet | 1.689256e-3 |
GO:0042989 | sequestering of actin monomers | 1.702033e-3 |
GO:0006505 | GPI anchor metabolic process | 1.710844e-3 |
GO:0019883 | antigen processing and presentation of endogenous antigen | 1.777721e-3 |
GO:0051055 | negative regulation of lipid biosynthetic process | 1.788333e-3 |
GO:0072070 | loop of Henle development | 1.819604e-3 |
GO:0060252 | positive regulation of glial cell proliferation | 1.819604e-3 |
GO:0002418 | immune response to tumor cell | 1.827671e-3 |
GO:0051586 | positive regulation of dopamine uptake | 1.854911e-3 |
GO:0060580 | ventral spinal cord interneuron fate determination | 1.854911e-3 |
GO:0046416 | D-amino acid metabolic process | 1.854911e-3 |
GO:0048210 | Golgi vesicle fusion to target membrane | 1.854911e-3 |
GO:0003327 | type B pancreatic cell fate commitment | 1.854911e-3 |
GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter | 1.923171e-3 |
GO:0060711 | labyrinthine layer development | 1.929122e-3 |
GO:0048352 | paraxial mesoderm structural organization | 1.957400e-3 |
GO:0021998 | neural plate mediolateral regionalization | 1.957400e-3 |
GO:0009440 | cyanate catabolic process | 1.957400e-3 |
GO:0035020 | regulation of Rac protein signal transduction | 1.977667e-3 |
GO:0030835 | negative regulation of actin filament depolymerization | 1.991683e-3 |
GO:0030490 | maturation of SSU-rRNA | 2.020020e-3 |
GO:0071496 | cellular response to external stimulus | 2.041220e-3 |
GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion | 2.057746e-3 |
GO:0033131 | regulation of glucokinase activity | 2.060383e-3 |
GO:0071956 | cellular component maintenance at cellular level | 2.067759e-3 |
GO:0042886 | amide transport | 2.067759e-3 |
GO:0021843 | substrate-independent telencephalic tangential interneuron migration | 2.082492e-3 |
GO:0002268 | follicular dendritic cell differentiation | 2.082492e-3 |
GO:0010893 | positive regulation of steroid biosynthetic process | 2.092918e-3 |
GO:0032321 | positive regulation of Rho GTPase activity | 2.153930e-3 |
GO:0045218 | zonula adherens maintenance | 2.179072e-3 |
GO:0016056 | rhodopsin mediated signaling pathway | 2.204570e-3 |
GO:0010912 | positive regulation of isomerase activity | 2.260832e-3 |
GO:0090205 | positive regulation of cholesterol metabolic process | 2.287208e-3 |
GO:0034097 | response to cytokine stimulus | 2.305056e-3 |
GO:0032984 | macromolecular complex disassembly | 2.320385e-3 |
GO:0006525 | arginine metabolic process | 2.377335e-3 |
GO:0006695 | cholesterol biosynthetic process | 2.377779e-3 |
GO:0008594 | photoreceptor cell morphogenesis | 2.382101e-3 |
GO:0045922 | negative regulation of fatty acid metabolic process | 2.389510e-3 |
GO:0051004 | regulation of lipoprotein lipase activity | 2.405062e-3 |
GO:0032365 | intracellular lipid transport | 2.405062e-3 |
GO:0060112 | generation of ovulation cycle rhythm | 2.459427e-3 |
GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway | 2.463422e-3 |
GO:0061370 | testosterone biosynthetic process | 2.463422e-3 |
GO:0033595 | response to genistein | 2.463422e-3 |
GO:0050756 | fractalkine metabolic process | 2.463422e-3 |
GO:0070842 | aggresome assembly | 2.469455e-3 |
GO:0060448 | dichotomous subdivision of terminal units involved in lung branching | 2.469455e-3 |
GO:0043304 | regulation of mast cell degranulation | 2.488057e-3 |
GO:0010745 | negative regulation of macrophage derived foam cell differentiation | 2.488057e-3 |
GO:0006097 | glyoxylate cycle | 2.491646e-3 |
GO:0040030 | regulation of molecular function, epigenetic | 2.491646e-3 |
GO:0065002 | intracellular protein transmembrane transport | 2.499155e-3 |
GO:0043628 | ncRNA 3'-end processing | 2.499155e-3 |
GO:0010984 | regulation of lipoprotein particle clearance | 2.559913e-3 |
GO:0015844 | monoamine transport | 2.612030e-3 |
GO:0032856 | activation of Ras GTPase activity | 2.632585e-3 |
GO:0000212 | meiotic spindle organization | 2.687408e-3 |
GO:0002357 | defense response to tumor cell | 2.694447e-3 |
GO:0008203 | cholesterol metabolic process | 2.726530e-3 |
GO:0000185 | activation of MAPKKK activity | 2.784772e-3 |
GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 2.867028e-3 |
GO:0030031 | cell projection assembly | 2.915435e-3 |
GO:0030224 | monocyte differentiation | 2.921382e-3 |
GO:0034612 | response to tumor necrosis factor | 3.022764e-3 |
GO:0090136 | epithelial cell-cell adhesion | 3.085743e-3 |
GO:0010872 | regulation of cholesterol esterification | 3.095456e-3 |
GO:0048570 | notochord morphogenesis | 3.122230e-3 |
GO:0048790 | maintenance of presynaptic active zone structure | 3.138339e-3 |
GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane | 3.138339e-3 |
GO:0045948 | positive regulation of translational initiation | 3.175366e-3 |
GO:0002115 | store-operated calcium entry | 3.231913e-3 |
GO:0008064 | regulation of actin polymerization or depolymerization | 3.234795e-3 |
GO:0060349 | bone morphogenesis | 3.243315e-3 |
GO:0051882 | mitochondrial depolarization | 3.315206e-3 |
GO:0060263 | regulation of respiratory burst | 3.326487e-3 |
GO:0015696 | ammonium transport | 3.350337e-3 |
GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway | 3.350337e-3 |
GO:0070602 | regulation of centromeric sister chromatid cohesion | 3.399331e-3 |
GO:0016242 | negative regulation of macroautophagy | 3.402525e-3 |
GO:0006669 | sphinganine-1-phosphate biosynthetic process | 3.402525e-3 |
GO:0006400 | tRNA modification | 3.432264e-3 |
GO:0003416 | endochondral bone growth | 3.437155e-3 |
GO:0016125 | sterol metabolic process | 3.457251e-3 |
GO:0045075 | regulation of interleukin-12 biosynthetic process | 3.495482e-3 |
GO:0046847 | filopodium assembly | 3.529137e-3 |
GO:0031331 | positive regulation of cellular catabolic process | 3.569926e-3 |
GO:0060236 | regulation of mitotic spindle organization | 3.585533e-3 |
GO:0034470 | ncRNA processing | 3.586368e-3 |
GO:0001916 | positive regulation of T cell mediated cytotoxicity | 3.703000e-3 |
GO:0048143 | astrocyte activation | 3.734210e-3 |
GO:0035722 | interleukin-12-mediated signaling pathway | 3.734210e-3 |
GO:0016557 | peroxisome membrane biogenesis | 3.779592e-3 |
GO:0008625 | induction of apoptosis via death domain receptors | 3.789107e-3 |
GO:0042278 | purine nucleoside metabolic process | 3.821300e-3 |
GO:0060290 | transdifferentiation | 3.869845e-3 |
GO:0032319 | regulation of Rho GTPase activity | 3.906763e-3 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 3.942263e-3 |
GO:0046502 | uroporphyrinogen III metabolic process | 3.993845e-3 |
GO:0034770 | histone H4-K20 methylation | 3.993845e-3 |
GO:0032049 | cardiolipin biosynthetic process | 3.993845e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0033239 | negative regulation of cellular amine metabolic process | 5.171475e-10 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 1.892120e-8 |
GO:0046580 | negative regulation of Ras protein signal transduction | 7.198656e-8 |
GO:0060696 | regulation of phospholipid catabolic process | 1.061468e-7 |
GO:0051058 | negative regulation of small GTPase mediated signal transduction | 2.724263e-7 |
GO:0046339 | diacylglycerol metabolic process | 3.251865e-7 |
GO:0042267 | natural killer cell mediated cytotoxicity | 5.194940e-7 |
GO:0032375 | negative regulation of cholesterol transport | 1.287886e-6 |
GO:0045723 | positive regulation of fatty acid biosynthetic process | 1.419402e-6 |
GO:0014819 | regulation of skeletal muscle contraction | 1.759433e-6 |
GO:0051135 | positive regulation of NK T cell activation | 1.799103e-6 |
GO:0018022 | peptidyl-lysine methylation | 1.805883e-6 |
GO:0006654 | phosphatidic acid biosynthetic process | 2.697620e-6 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 5.595609e-6 |
GO:0090208 | positive regulation of triglyceride metabolic process | 5.796344e-6 |
GO:0015884 | folic acid transport | 6.207697e-6 |
GO:0010898 | positive regulation of triglyceride catabolic process | 7.814284e-6 |
GO:0032374 | regulation of cholesterol transport | 7.862152e-6 |
GO:0046015 | regulation of transcription by glucose | 8.913295e-6 |
GO:0050728 | negative regulation of inflammatory response | 9.145031e-6 |
GO:0030421 | defecation | 9.357682e-6 |
GO:0032049 | cardiolipin biosynthetic process | 9.457748e-6 |
GO:0001909 | leukocyte mediated cytotoxicity | 9.688516e-6 |
GO:0010565 | regulation of cellular ketone metabolic process | 1.141560e-5 |
GO:0034447 | very-low-density lipoprotein particle clearance | 1.395667e-5 |
GO:0061014 | positive regulation of mRNA catabolic process | 1.508030e-5 |
GO:0051181 | cofactor transport | 1.662969e-5 |
GO:0015718 | monocarboxylic acid transport | 1.946385e-5 |
GO:0015908 | fatty acid transport | 2.039113e-5 |
GO:0034261 | negative regulation of Ras GTPase activity | 2.145713e-5 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 2.158168e-5 |
GO:0048240 | sperm capacitation | 2.675085e-5 |
GO:0001829 | trophectodermal cell differentiation | 2.924906e-5 |
GO:0035966 | response to topologically incorrect protein | 3.224511e-5 |
GO:0018023 | peptidyl-lysine trimethylation | 3.231556e-5 |
GO:0010614 | negative regulation of cardiac muscle hypertrophy | 3.780494e-5 |
GO:0072012 | glomerulus vasculature development | 3.845256e-5 |
GO:0070509 | calcium ion import | 3.882682e-5 |
GO:0015891 | siderophore transport | 4.153959e-5 |
GO:0010906 | regulation of glucose metabolic process | 4.250439e-5 |
GO:0014741 | negative regulation of muscle hypertrophy | 4.452728e-5 |
GO:0033700 | phospholipid efflux | 4.981803e-5 |
GO:0032012 | regulation of ARF protein signal transduction | 5.044059e-5 |
GO:0042304 | regulation of fatty acid biosynthetic process | 5.125711e-5 |
GO:2000251 | positive regulation of actin cytoskeleton reorganization | 5.554454e-5 |
GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein | 5.963492e-5 |
GO:0016575 | histone deacetylation | 7.539617e-5 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 7.936980e-5 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 8.872900e-5 |
GO:0033344 | cholesterol efflux | 8.949723e-5 |
GO:0051693 | actin filament capping | 9.005849e-5 |
GO:0043320 | natural killer cell degranulation | 9.139780e-5 |
GO:0006474 | N-terminal protein amino acid acetylation | 9.621157e-5 |
GO:0090207 | regulation of triglyceride metabolic process | 9.802691e-5 |
GO:0015909 | long-chain fatty acid transport | 9.802691e-5 |
GO:0071715 | icosanoid transport | 9.868526e-5 |
GO:0000305 | response to oxygen radical | 1.019873e-4 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 1.038293e-4 |
GO:0071506 | cellular response to mycophenolic acid | 1.038293e-4 |
GO:0060457 | negative regulation of digestive system process | 1.087265e-4 |
GO:0061370 | testosterone biosynthetic process | 1.165562e-4 |
GO:0006415 | translational termination | 1.269368e-4 |
GO:0090130 | tissue migration | 1.330470e-4 |
GO:0018026 | peptidyl-lysine monomethylation | 1.387698e-4 |
GO:0046889 | positive regulation of lipid biosynthetic process | 1.456970e-4 |
GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway | 1.461322e-4 |
GO:0034260 | negative regulation of GTPase activity | 1.488235e-4 |
GO:0045026 | plasma membrane fusion | 1.520419e-4 |
GO:0045014 | negative regulation of transcription by glucose | 1.615308e-4 |
GO:0010870 | positive regulation of receptor biosynthetic process | 1.615308e-4 |
GO:0017156 | calcium ion-dependent exocytosis | 1.659795e-4 |
GO:0010452 | histone H3-K36 methylation | 1.665925e-4 |
GO:0045834 | positive regulation of lipid metabolic process | 1.913926e-4 |
GO:0061034 | olfactory bulb mitral cell layer development | 2.046562e-4 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 2.052513e-4 |
GO:0045351 | type I interferon biosynthetic process | 2.052985e-4 |
GO:0043154 | negative regulation of caspase activity | 2.220852e-4 |
GO:0060014 | granulosa cell differentiation | 2.337021e-4 |
GO:0045835 | negative regulation of meiosis | 2.386792e-4 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 2.443448e-4 |
GO:0015914 | phospholipid transport | 2.819905e-4 |
GO:0035601 | protein deacylation | 2.869831e-4 |
GO:0051788 | response to misfolded protein | 3.184060e-4 |
GO:0010224 | response to UV-B | 3.205383e-4 |
GO:0010948 | negative regulation of cell cycle process | 3.216462e-4 |
GO:0031444 | slow-twitch skeletal muscle fiber contraction | 3.224768e-4 |
GO:0060290 | transdifferentiation | 3.313278e-4 |
GO:0032369 | negative regulation of lipid transport | 3.631737e-4 |
GO:0031331 | positive regulation of cellular catabolic process | 3.673309e-4 |
GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus | 3.778519e-4 |
GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion | 3.778519e-4 |
GO:0002886 | regulation of myeloid leukocyte mediated immunity | 3.797845e-4 |
GO:0007342 | fusion of sperm to egg plasma membrane | 4.042167e-4 |
GO:0046168 | glycerol-3-phosphate catabolic process | 4.100911e-4 |
GO:0042506 | tyrosine phosphorylation of Stat5 protein | 4.100911e-4 |
GO:0016338 | calcium-independent cell-cell adhesion | 4.113599e-4 |
GO:0006651 | diacylglycerol biosynthetic process | 4.271727e-4 |
GO:0072668 | tubulin complex biogenesis | 4.557492e-4 |
GO:0001885 | endothelial cell development | 4.735518e-4 |
GO:0006476 | protein deacetylation | 5.004866e-4 |
GO:0046686 | response to cadmium ion | 5.080162e-4 |
GO:0030913 | paranodal junction assembly | 5.088249e-4 |
GO:0071072 | negative regulation of phospholipid biosynthetic process | 5.112275e-4 |
GO:0031365 | N-terminal protein amino acid modification | 5.324635e-4 |
GO:0032048 | cardiolipin metabolic process | 5.399105e-4 |
GO:0046655 | folic acid metabolic process | 5.399105e-4 |
GO:0030834 | regulation of actin filament depolymerization | 5.416636e-4 |
GO:0035307 | positive regulation of protein dephosphorylation | 5.531146e-4 |
GO:0050482 | arachidonic acid secretion | 5.729584e-4 |
GO:0032007 | negative regulation of TOR signaling cascade | 5.740235e-4 |
GO:0016188 | synaptic vesicle maturation | 5.759335e-4 |
GO:0000096 | sulfur amino acid metabolic process | 5.988658e-4 |
GO:0002385 | mucosal immune response | 6.117846e-4 |
GO:0042593 | glucose homeostasis | 6.248491e-4 |
GO:0009082 | branched chain family amino acid biosynthetic process | 6.358155e-4 |
GO:0031448 | positive regulation of fast-twitch skeletal muscle fiber contraction | 6.424478e-4 |
GO:0030336 | negative regulation of cell migration | 6.538390e-4 |
GO:0032312 | regulation of ARF GTPase activity | 6.726159e-4 |
GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 6.769654e-4 |
GO:0072110 | glomerular mesangial cell proliferation | 6.822107e-4 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 6.997428e-4 |
GO:0032429 | regulation of phospholipase A2 activity | 7.020216e-4 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 7.070642e-4 |
GO:0034382 | chylomicron remnant clearance | 7.435029e-4 |
GO:0042946 | glucoside transport | 7.609189e-4 |
GO:0002432 | granuloma formation | 7.609189e-4 |
GO:0006420 | arginyl-tRNA aminoacylation | 7.609189e-4 |
GO:0033238 | regulation of cellular amine metabolic process | 7.707948e-4 |
GO:0090177 | establishment of planar polarity involved in neural tube closure | 7.880546e-4 |
GO:0010312 | detoxification of zinc ion | 7.880546e-4 |
GO:0035306 | positive regulation of dephosphorylation | 7.887490e-4 |
GO:2000227 | negative regulation of pancreatic A cell differentiation | 8.394337e-4 |
GO:2000978 | negative regulation of forebrain neuron differentiation | 8.394337e-4 |
GO:0061106 | negative regulation of stomach neuroendocrine cell differentiation | 8.394337e-4 |
GO:0046331 | lateral inhibition | 8.394337e-4 |
GO:0032863 | activation of Rac GTPase activity | 8.452407e-4 |
GO:0072109 | glomerular mesangium development | 8.647117e-4 |
GO:0042420 | dopamine catabolic process | 8.843617e-4 |
GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 8.843617e-4 |
GO:0018342 | protein prenylation | 8.964016e-4 |
GO:0044062 | regulation of excretion | 9.012399e-4 |
GO:0014067 | negative regulation of phosphatidylinositol 3-kinase cascade | 9.403415e-4 |
GO:0015724 | formate transport | 9.612107e-4 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 9.612107e-4 |
GO:0000059 | protein import into nucleus, docking | 9.612107e-4 |
GO:0003219 | cardiac right ventricle formation | 9.660202e-4 |
GO:0042107 | cytokine metabolic process | 9.777673e-4 |
GO:0046717 | acid secretion | 1.008335e-3 |
GO:0006700 | C21-steroid hormone biosynthetic process | 1.014859e-3 |
GO:0043314 | negative regulation of neutrophil degranulation | 1.021818e-3 |
GO:0018198 | peptidyl-cysteine modification | 1.024667e-3 |
GO:0043301 | negative regulation of leukocyte degranulation | 1.107480e-3 |
GO:0006837 | serotonin transport | 1.107480e-3 |
GO:0000303 | response to superoxide | 1.136167e-3 |
GO:0006546 | glycine catabolic process | 1.165184e-3 |
GO:0043300 | regulation of leukocyte degranulation | 1.188895e-3 |
GO:0050994 | regulation of lipid catabolic process | 1.218595e-3 |
GO:0032272 | negative regulation of protein polymerization | 1.227810e-3 |
GO:0019318 | hexose metabolic process | 1.229869e-3 |
GO:0002251 | organ or tissue specific immune response | 1.250515e-3 |
GO:0010984 | regulation of lipoprotein particle clearance | 1.251608e-3 |
GO:2000210 | positive regulation of anoikis | 1.303052e-3 |
GO:0032020 | ISG15-protein conjugation | 1.416629e-3 |
GO:2000491 | positive regulation of hepatic stellate cell activation | 1.419724e-3 |
GO:0055014 | atrial cardiac muscle cell development | 1.475032e-3 |
GO:0021558 | trochlear nerve development | 1.475032e-3 |
GO:0019430 | removal of superoxide radicals | 1.484561e-3 |
GO:0032862 | activation of Rho GTPase activity | 1.496304e-3 |
GO:0048664 | neuron fate determination | 1.497273e-3 |
GO:0060160 | negative regulation of dopamine receptor signaling pathway | 1.504306e-3 |
GO:0045796 | negative regulation of intestinal cholesterol absorption | 1.504306e-3 |
GO:0071877 | regulation of adrenergic receptor signaling pathway | 1.504306e-3 |
GO:0035419 | activation of MAPK activity involved in innate immune response | 1.504306e-3 |
GO:0010949 | negative regulation of intestinal phytosterol absorption | 1.504306e-3 |
GO:0034635 | glutathione transport | 1.504306e-3 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 1.521104e-3 |
GO:0005978 | glycogen biosynthetic process | 1.528880e-3 |
GO:0000083 | regulation of transcription involved in G1/S phase of mitotic cell cycle | 1.535744e-3 |
GO:0051488 | activation of anaphase-promoting complex activity | 1.540953e-3 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 1.541273e-3 |
GO:0006620 | posttranslational protein targeting to membrane | 1.560282e-3 |
GO:0046890 | regulation of lipid biosynthetic process | 1.586552e-3 |
GO:0090076 | relaxation of skeletal muscle | 1.636254e-3 |
GO:0032470 | elevation of endoplasmic reticulum calcium ion concentration | 1.636254e-3 |
GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway | 1.647168e-3 |
GO:0019217 | regulation of fatty acid metabolic process | 1.675985e-3 |
GO:0060191 | regulation of lipase activity | 1.684270e-3 |
GO:0001825 | blastocyst formation | 1.700588e-3 |
GO:0035094 | response to nicotine | 1.745804e-3 |
GO:0046341 | CDP-diacylglycerol metabolic process | 1.777120e-3 |
GO:0010735 | positive regulation of transcription via serum response element binding | 1.777120e-3 |
GO:0006109 | regulation of carbohydrate metabolic process | 1.791611e-3 |
GO:0033085 | negative regulation of T cell differentiation in thymus | 1.830640e-3 |
GO:0021679 | cerebellar molecular layer development | 1.847045e-3 |
GO:0021750 | vestibular nucleus development | 1.847045e-3 |
GO:0021590 | cerebellum maturation | 1.847045e-3 |
GO:0017004 | cytochrome complex assembly | 1.847045e-3 |
GO:0000072 | M phase specific microtubule process | 1.847045e-3 |
GO:0043278 | response to morphine | 1.917475e-3 |
GO:0060561 | apoptosis involved in morphogenesis | 1.924348e-3 |
GO:0032321 | positive regulation of Rho GTPase activity | 1.983369e-3 |
GO:0010631 | epithelial cell migration | 2.005486e-3 |
GO:0010675 | regulation of cellular carbohydrate metabolic process | 2.023682e-3 |
GO:0007290 | spermatid nucleus elongation | 2.038492e-3 |
GO:0042228 | interleukin-8 biosynthetic process | 2.080072e-3 |
GO:0032782 | bile acid secretion | 2.080072e-3 |
GO:0051447 | negative regulation of meiotic cell cycle | 2.080072e-3 |
GO:0003096 | renal sodium ion transport | 2.080072e-3 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 2.080072e-3 |
GO:0006986 | response to unfolded protein | 2.084962e-3 |
GO:0007339 | binding of sperm to zona pellucida | 2.103817e-3 |
GO:0031440 | regulation of mRNA 3'-end processing | 2.118323e-3 |
GO:0021555 | midbrain-hindbrain boundary morphogenesis | 2.118323e-3 |
GO:0032368 | regulation of lipid transport | 2.135527e-3 |
GO:0007021 | tubulin complex assembly | 2.145721e-3 |
GO:0060490 | lateral sprouting involved in lung morphogenesis | 2.164230e-3 |
GO:0060489 | planar dichotomous subdivision of terminal units involved in lung branching morphogenesis | 2.164230e-3 |
GO:0048105 | establishment of body hair planar orientation | 2.164230e-3 |
GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis | 2.164230e-3 |
GO:0031329 | regulation of cellular catabolic process | 2.188430e-3 |
GO:0009081 | branched chain family amino acid metabolic process | 2.203635e-3 |
GO:0045792 | negative regulation of cell size | 2.304953e-3 |
GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway | 2.313770e-3 |
GO:0030835 | negative regulation of actin filament depolymerization | 2.325211e-3 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 2.325361e-3 |
GO:0061196 | fungiform papilla development | 2.356370e-3 |
GO:0071071 | regulation of phospholipid biosynthetic process | 2.379709e-3 |
GO:0046340 | diacylglycerol catabolic process | 2.404116e-3 |
GO:0090234 | regulation of kinetochore assembly | 2.415655e-3 |
GO:0061088 | regulation of sequestering of zinc ion | 2.415655e-3 |
GO:0090169 | regulation of spindle assembly | 2.415655e-3 |
GO:0051781 | positive regulation of cell division | 2.432478e-3 |
GO:0045923 | positive regulation of fatty acid metabolic process | 2.445719e-3 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 2.553254e-3 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.553254e-3 |
GO:0018101 | peptidyl-citrulline biosynthetic process from peptidyl-arginine | 2.553254e-3 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.553254e-3 |
GO:0051323 | metaphase | 2.579221e-3 |
GO:0030002 | cellular anion homeostasis | 2.783383e-3 |
GO:0009912 | auditory receptor cell fate commitment | 2.792445e-3 |
GO:0006006 | glucose metabolic process | 2.823735e-3 |
GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | 2.833416e-3 |
GO:2000273 | positive regulation of receptor activity | 2.835310e-3 |
GO:0046755 | non-lytic virus budding | 2.847638e-3 |
GO:0055026 | negative regulation of cardiac muscle tissue development | 2.847638e-3 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 2.847638e-3 |
GO:0070831 | basement membrane assembly | 2.847638e-3 |
GO:0006391 | transcription initiation from mitochondrial promoter | 2.847638e-3 |
GO:0018364 | peptidyl-glutamine methylation | 2.847638e-3 |
GO:0032971 | regulation of muscle filament sliding | 2.847638e-3 |
GO:0061308 | cardiac neural crest cell development involved in heart development | 2.893529e-3 |
GO:0045608 | negative regulation of auditory receptor cell differentiation | 2.953755e-3 |
GO:0033211 | adiponectin-mediated signaling pathway | 3.034815e-3 |
GO:0019388 | galactose catabolic process | 3.051919e-3 |
GO:0032606 | type I interferon production | 3.052549e-3 |
GO:0043353 | enucleate erythrocyte differentiation | 3.052549e-3 |
GO:0007217 | tachykinin receptor signaling pathway | 3.052549e-3 |
GO:0060193 | positive regulation of lipase activity | 3.098597e-3 |
GO:0035441 | cell migration involved in vasculogenesis | 3.121000e-3 |
GO:0010868 | negative regulation of triglyceride biosynthetic process | 3.145072e-3 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 3.216174e-3 |
GO:0010896 | regulation of triglyceride catabolic process | 3.272629e-3 |
GO:0045017 | glycerolipid biosynthetic process | 3.306427e-3 |
GO:0045721 | negative regulation of gluconeogenesis | 3.395494e-3 |
GO:0006998 | nuclear envelope organization | 3.501155e-3 |
GO:0097150 | neuronal stem cell maintenance | 3.582646e-3 |
GO:0090002 | establishment of protein localization in plasma membrane | 3.582646e-3 |
GO:0061198 | fungiform papilla formation | 3.582646e-3 |
GO:0032328 | alanine transport | 3.582646e-3 |
GO:0043313 | regulation of neutrophil degranulation | 3.725007e-3 |
GO:0035907 | dorsal aorta development | 3.788014e-3 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 3.788014e-3 |
GO:0034498 | early endosome to Golgi transport | 3.797810e-3 |
GO:2000146 | negative regulation of cell motility | 3.817781e-3 |
GO:0051156 | glucose 6-phosphate metabolic process | 3.878596e-3 |
GO:0010874 | regulation of cholesterol efflux | 3.922311e-3 |
GO:0009083 | branched chain family amino acid catabolic process | 3.992056e-3 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 4.017318e-3 |
GO:0006116 | NADH oxidation | 4.056238e-3 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 4.056238e-3 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 4.083934e-3 |
GO:0031117 | positive regulation of microtubule depolymerization | 4.139349e-3 |
GO:0060158 | activation of phospholipase C activity by dopamine receptor signaling pathway | 4.139349e-3 |
GO:0000432 | positive regulation of transcription from RNA polymerase II promoter by glucose | 4.139349e-3 |
GO:0035814 | negative regulation of renal sodium excretion | 4.161737e-3 |
GO:0032984 | macromolecular complex disassembly | 4.226824e-3 |
GO:0071173 | spindle assembly checkpoint | 4.309846e-3 |
GO:0033131 | regulation of glucokinase activity | 4.309846e-3 |
GO:0010907 | positive regulation of glucose metabolic process | 4.354087e-3 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 4.388580e-3 |
GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis | 4.418035e-3 |
GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process | 4.501257e-3 |
GO:0055107 | Golgi to secretory granule transport | 4.501257e-3 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 4.501257e-3 |
GO:0060385 | axonogenesis involved in innervation | 4.501257e-3 |
GO:0015878 | biotin transport | 4.501257e-3 |
GO:0015887 | pantothenate transmembrane transport | 4.501257e-3 |
GO:0032972 | regulation of muscle filament sliding speed | 4.501257e-3 |
GO:0034651 | cortisol biosynthetic process | 4.501257e-3 |
GO:0035865 | cellular response to potassium ion | 4.501257e-3 |
GO:0043547 | positive regulation of GTPase activity | 4.505285e-3 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 4.513365e-3 |
GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis | 4.608061e-3 |
GO:0060695 | negative regulation of cholesterol transporter activity | 4.608061e-3 |
GO:0050756 | fractalkine metabolic process | 4.608061e-3 |
GO:0033595 | response to genistein | 4.608061e-3 |
GO:0006701 | progesterone biosynthetic process | 4.608061e-3 |
GO:0015759 | beta-glucoside transport | 4.608061e-3 |
GO:0051497 | negative regulation of stress fiber assembly | 4.641474e-3 |
GO:0018094 | protein polyglycylation | 4.675208e-3 |
GO:0050996 | positive regulation of lipid catabolic process | 4.739643e-3 |
GO:0072333 | signal transduction by p53 class mediator resulting in induction of anoikis | 4.761419e-3 |
GO:0070375 | BMK cascade | 4.761419e-3 |
GO:0032318 | regulation of Ras GTPase activity | 4.791943e-3 |
GO:0042668 | auditory receptor cell fate determination | 5.025146e-3 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 5.081056e-3 |
GO:0060448 | dichotomous subdivision of terminal units involved in lung branching | 5.088422e-3 |
GO:0019405 | alditol catabolic process | 5.088422e-3 |
GO:0061028 | establishment of endothelial barrier | 5.111692e-3 |
GO:0031577 | spindle checkpoint | 5.180414e-3 |
GO:0035583 | negative regulation of transforming growth factor beta receptor signaling pathway by extracellular sequestering of TGFbeta | 5.183687e-3 |
GO:0019532 | oxalate transport | 5.183687e-3 |
GO:0021681 | cerebellar granular layer development | 5.296586e-3 |
GO:0072337 | modified amino acid transport | 5.308747e-3 |
GO:0072011 | glomerular endothelium development | 5.339353e-3 |
GO:2000188 | regulation of cholesterol homeostasis | 5.339353e-3 |
GO:0046333 | octopamine metabolic process | 5.339353e-3 |
GO:0042309 | homoiothermy | 5.339353e-3 |
GO:0007168 | receptor guanylyl cyclase signaling pathway | 5.395041e-3 |
GO:0021578 | hindbrain maturation | 5.395041e-3 |
GO:0001835 | blastocyst hatching | 5.395041e-3 |
GO:2000974 | negative regulation of pro-B cell differentiation | 5.465941e-3 |
GO:0030644 | cellular chloride ion homeostasis | 5.465941e-3 |
GO:0071218 | cellular response to misfolded protein | 5.499189e-3 |
GO:0030718 | germ-line stem cell maintenance | 5.499189e-3 |
GO:0008078 | mesodermal cell migration | 5.514617e-3 |
GO:0071879 | positive regulation of adrenergic receptor signaling pathway | 5.614529e-3 |
GO:0070267 | oncosis | 5.614529e-3 |
GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development | 5.614529e-3 |
GO:0048243 | norepinephrine secretion | 5.614529e-3 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 5.665852e-3 |
GO:0002674 | negative regulation of acute inflammatory response | 5.717867e-3 |
GO:0048635 | negative regulation of muscle organ development | 5.720689e-3 |
GO:0046688 | response to copper ion | 5.732293e-3 |
GO:0022038 | corpus callosum development | 5.923208e-3 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 6.004133e-3 |
GO:0060347 | heart trabecula formation | 6.004215e-3 |
GO:0006354 | transcription elongation, DNA-dependent | 6.026648e-3 |
GO:0007340 | acrosome reaction | 6.143639e-3 |
GO:0070972 | protein localization in endoplasmic reticulum | 6.151919e-3 |
GO:0009166 | nucleotide catabolic process | 6.188023e-3 |
GO:0097039 | protein linear polyubiquitination | 6.189269e-3 |
GO:0045047 | protein targeting to ER | 6.279868e-3 |
GO:0015698 | inorganic anion transport | 6.302107e-3 |
GO:0046499 | S-adenosylmethioninamine metabolic process | 6.340508e-3 |
GO:0045345 | positive regulation of MHC class I biosynthetic process | 6.588717e-3 |
GO:0045875 | negative regulation of sister chromatid cohesion | 6.588717e-3 |
GO:0033278 | cell proliferation in midbrain | 6.588717e-3 |
GO:0006669 | sphinganine-1-phosphate biosynthetic process | 6.588717e-3 |
GO:0046886 | positive regulation of hormone biosynthetic process | 6.606481e-3 |
GO:0071333 | cellular response to glucose stimulus | 6.657928e-3 |
GO:0000089 | mitotic metaphase | 6.663848e-3 |
GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter | 6.677581e-3 |
GO:0072078 | nephron tubule morphogenesis | 6.698269e-3 |
GO:0032320 | positive regulation of Ras GTPase activity | 6.744679e-3 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 6.768494e-3 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 6.768494e-3 |
GO:0051387 | negative regulation of nerve growth factor receptor signaling pathway | 6.768494e-3 |
GO:0044275 | cellular carbohydrate catabolic process | 6.834114e-3 |
GO:0032700 | negative regulation of interleukin-17 production | 6.835693e-3 |
GO:0007143 | female meiosis | 6.835693e-3 |
GO:0051051 | negative regulation of transport | 6.886817e-3 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 6.975315e-3 |
GO:0002426 | immunoglobulin production in mucosal tissue | 6.975315e-3 |
GO:0051186 | cofactor metabolic process | 7.044149e-3 |
GO:0010866 | regulation of triglyceride biosynthetic process | 7.072275e-3 |
GO:0006997 | nucleus organization | 7.073187e-3 |
GO:0051983 | regulation of chromosome segregation | 7.094821e-3 |
GO:0072141 | renal interstitial cell development | 7.190671e-3 |
GO:0045332 | phospholipid translocation | 7.190671e-3 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 7.249140e-3 |
GO:0006111 | regulation of gluconeogenesis | 7.256543e-3 |
GO:0071322 | cellular response to carbohydrate stimulus | 7.291280e-3 |
GO:2000981 | negative regulation of inner ear receptor cell differentiation | 7.318512e-3 |
GO:0071321 | cellular response to cGMP | 7.319049e-3 |
GO:0030046 | parallel actin filament bundle assembly | 7.319049e-3 |
GO:0060978 | angiogenesis involved in coronary vascular morphogenesis | 7.319049e-3 |
GO:0035095 | behavioral response to nicotine | 7.319049e-3 |
GO:0032418 | lysosome localization | 7.319049e-3 |
GO:0032874 | positive regulation of stress-activated MAPK cascade | 7.350179e-3 |
GO:0045988 | negative regulation of striated muscle contraction | 7.465791e-3 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 7.478102e-3 |
GO:0016601 | Rac protein signal transduction | 7.567056e-3 |
GO:0010875 | positive regulation of cholesterol efflux | 7.589902e-3 |
GO:0007063 | regulation of sister chromatid cohesion | 7.599317e-3 |
GO:0051055 | negative regulation of lipid biosynthetic process | 7.771945e-3 |
GO:0005979 | regulation of glycogen biosynthetic process | 7.775926e-3 |
GO:0006337 | nucleosome disassembly | 7.925446e-3 |
GO:0022616 | DNA strand elongation | 8.199788e-3 |
GO:0050668 | positive regulation of homocysteine metabolic process | 8.220967e-3 |
GO:0070845 | polyubiquitinated misfolded protein transport | 8.220967e-3 |
GO:0045963 | negative regulation of dopamine metabolic process | 8.220967e-3 |
GO:0043255 | regulation of carbohydrate biosynthetic process | 8.240951e-3 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | 8.346069e-3 |
GO:0006821 | chloride transport | 8.360567e-3 |
GO:0072239 | metanephric glomerulus vasculature development | 8.389517e-3 |
GO:0001820 | serotonin secretion | 8.389517e-3 |
GO:0048733 | sebaceous gland development | 8.462406e-3 |
GO:0033159 | negative regulation of protein import into nucleus, translocation | 8.462406e-3 |
GO:0019853 | L-ascorbic acid biosynthetic process | 8.493189e-3 |
GO:0017144 | drug metabolic process | 8.646446e-3 |
GO:0072539 | T-helper 17 cell differentiation | 8.698550e-3 |
GO:0046942 | carboxylic acid transport | 8.772036e-3 |
GO:0001678 | cellular glucose homeostasis | 8.811087e-3 |
GO:0051403 | stress-activated MAPK cascade | 8.844998e-3 |
GO:0006659 | phosphatidylserine biosynthetic process | 8.844998e-3 |
GO:0061072 | iris morphogenesis | 8.890375e-3 |
GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis | 8.890375e-3 |
GO:0015874 | norepinephrine transport | 8.890375e-3 |
GO:0001893 | maternal placenta development | 8.908791e-3 |
GO:0014045 | establishment of endothelial blood-brain barrier | 9.132947e-3 |
GO:0030837 | negative regulation of actin filament polymerization | 9.176719e-3 |
GO:0016045 | detection of bacterium | 9.291149e-3 |
GO:0016052 | carbohydrate catabolic process | 9.422448e-3 |
GO:0042398 | cellular modified amino acid biosynthetic process | 9.447810e-3 |
GO:0006071 | glycerol metabolic process | 9.533169e-3 |
GO:0032856 | activation of Ras GTPase activity | 9.600111e-3 |
GO:0060192 | negative regulation of lipase activity | 9.605368e-3 |
GO:0019320 | hexose catabolic process | 9.714836e-3 |
GO:0045607 | regulation of auditory receptor cell differentiation | 9.729263e-3 |
GO:0042424 | catecholamine catabolic process | 9.729263e-3 |
GO:0000052 | citrulline metabolic process | 9.729263e-3 |
GO:0045872 | positive regulation of rhodopsin gene expression | 9.740582e-3 |
GO:0061144 | alveolar secondary septum development | 9.740582e-3 |
GO:0051041 | positive regulation of calcium-independent cell-cell adhesion | 9.740582e-3 |
GO:0032065 | cortical protein anchoring | 9.740582e-3 |
GO:0021528 | commissural neuron differentiation in spinal cord | 9.740582e-3 |
GO:0019086 | late viral mRNA transcription | 9.740582e-3 |
GO:0001886 | endothelial cell morphogenesis | 9.741157e-3 |
GO:0003015 | heart process | 9.782525e-3 |
GO:0072086 | specification of loop of Henle identity | 9.812979e-3 |
GO:0008654 | phospholipid biosynthetic process | 9.864293e-3 |
GO:0072385 | minus-end-directed organelle transport along microtubule | 9.901874e-3 |
GO:0023035 | CD40 signaling pathway | 9.901874e-3 |
GO:0070873 | regulation of glycogen metabolic process | 1.011071e-2 |
GO:0034393 | positive regulation of smooth muscle cell apoptosis | 1.015318e-2 |
GO:0006801 | superoxide metabolic process | 1.015786e-2 |
GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process | 1.055538e-2 |
GO:0051302 | regulation of cell division | 1.057820e-2 |
GO:0045833 | negative regulation of lipid metabolic process | 1.070122e-2 |
GO:0050883 | musculoskeletal movement, spinal reflex action | 1.074283e-2 |
GO:0033504 | floor plate development | 1.074283e-2 |
GO:0071593 | lymphocyte aggregation | 1.086840e-2 |
GO:0015886 | heme transport | 1.086840e-2 |
GO:0070869 | heterochromatin formation involved in chromatin silencing | 1.086840e-2 |
GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide | 1.086840e-2 |
GO:0009299 | mRNA transcription | 1.086840e-2 |
GO:0006668 | sphinganine-1-phosphate metabolic process | 1.086840e-2 |
GO:0071584 | negative regulation of zinc ion import | 1.103096e-2 |
GO:0071594 | thymocyte aggregation | 1.103096e-2 |
GO:0090281 | negative regulation of calcium ion import | 1.103096e-2 |
GO:0046967 | cytosol to ER transport | 1.103096e-2 |
GO:0019060 | intracellular transport of viral proteins in host cell | 1.103096e-2 |
GO:0006196 | AMP catabolic process | 1.103096e-2 |
GO:0046108 | uridine metabolic process | 1.103096e-2 |
GO:0034259 | negative regulation of Rho GTPase activity | 1.103096e-2 |
GO:0046086 | adenosine biosynthetic process | 1.103096e-2 |
GO:0018193 | peptidyl-amino acid modification | 1.115376e-2 |
GO:0051494 | negative regulation of cytoskeleton organization | 1.120487e-2 |
GO:2000142 | regulation of transcription initiation, DNA-dependent | 1.124714e-2 |
GO:0070914 | UV-damage excision repair | 1.128618e-2 |
GO:0090292 | nuclear matrix anchoring at nuclear membrane | 1.128618e-2 |
GO:0044342 | type B pancreatic cell proliferation | 1.128618e-2 |
GO:0042996 | regulation of Golgi to plasma membrane protein transport | 1.128618e-2 |
GO:0001830 | trophectodermal cell fate commitment | 1.128618e-2 |
GO:0018343 | protein farnesylation | 1.128618e-2 |
GO:0035562 | negative regulation of chromatin binding | 1.128618e-2 |
GO:0034227 | tRNA thio-modification | 1.132410e-2 |
GO:0006177 | GMP biosynthetic process | 1.132410e-2 |
GO:0015864 | pyrimidine nucleoside transport | 1.132410e-2 |
GO:0033591 | response to L-ascorbic acid | 1.137066e-2 |
GO:0050685 | positive regulation of mRNA processing | 1.150301e-2 |
GO:0007184 | SMAD protein import into nucleus | 1.162908e-2 |
GO:0015849 | organic acid transport | 1.177559e-2 |
GO:0006544 | glycine metabolic process | 1.184915e-2 |
GO:0010724 | regulation of definitive erythrocyte differentiation | 1.186231e-2 |
GO:0006705 | mineralocorticoid biosynthetic process | 1.186231e-2 |
GO:0090150 | establishment of protein localization in membrane | 1.215759e-2 |
GO:0002758 | innate immune response-activating signal transduction | 1.218909e-2 |
GO:0060047 | heart contraction | 1.223879e-2 |
GO:0035036 | sperm-egg recognition | 1.238209e-2 |
GO:0035813 | regulation of renal sodium excretion | 1.250830e-2 |
GO:0032872 | regulation of stress-activated MAPK cascade | 1.264077e-2 |
GO:0019511 | peptidyl-proline hydroxylation | 1.265086e-2 |
GO:0008633 | activation of pro-apoptotic gene products | 1.271285e-2 |
GO:0010824 | regulation of centrosome duplication | 1.282132e-2 |
GO:0045930 | negative regulation of mitotic cell cycle | 1.286673e-2 |
GO:0046174 | polyol catabolic process | 1.287111e-2 |
GO:0045541 | negative regulation of cholesterol biosynthetic process | 1.287111e-2 |
GO:0034329 | cell junction assembly | 1.291829e-2 |